Version 2.72

88889-1Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with non-probe detectionActive

Term Description

This assay detects nucleic acid sequences from Middle east respiratory syndrome coronavirus (MERS-CoV) RNA in nasopharyngeal swabs using PCR and non-probe detection methods, such as melt curve analysis. This term was created for, but not limited in use to, BioFire Diagnostic FilmArray Respiratory Panel 2 Plus assay.
Source: Regenstrief LOINC

Part Description

LP173753-7   Middle East respiratory syndrome coronavirus
Middle East Respiratory Syndrome (MERS) is an illness caused by the virus Middle East Respiratory Syndrome Coronovirus (MERS-CoV). The illness was first reported in Saudi Arabia in 2012, but was later found to have originated in Jordan in 2012. MERS has been found in camels leading to speculation that they may be the initial reservoir for the virus. The largest outbreak of MERS that has occurred outside of the Arabian Peninsula was in the Republic of Korea in 2015 and was linked to an individual who had been traveling in the Arabian Peninsula. The virus is probably spread through respiratory secretions from infected individuals though the exact mode of transmission is under investigation. Infection with MERS begins with an incubation period of 5-6 days followed by a severe acute illness that involves fever, shortness of breath and for patients with comorbidities or reduced immunity can lead to pneumonia and kidney failure. The mortality rate of MERS is 3-4 out of 10 people who are infected, though most of the people who die have underlying conditions. In addition, some people experience only cold-like symptoms and others have no symptoms at all. In the United States, most state laboratories are approved to test for MERS-CoV using the real-time reverse transcription-PCR assay developed by the CDC. The assay can be run on respiratory, serum and stool specimens.[CDC:coronavirus/mers] Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Regenstrief LOINC, Coronavirus (Wikipedia)

Fully-Specified Name

Middle east respiratory syndrome coronavirus RNA

Additional Names

Short Name
MERS-CoV RNA Nph Ql NAA+non-probe
Display Name
MERS-CoV RNA NAA+non-probe Ql (Nph)
Consumer Name Alpha
Middle East respiratory syndrome coronavirus (MERS-CoV), Nasopharynx

Example Answer List LL744-4

Source: Regenstrief Institute

Answer Code Score Answer ID
Detected LA11882-0
Not detected LA11883-8

Basic Attributes

First Released
Version 2.64
Last Updated
Version 2.64
Order vs. Observation

Member of these Panels

LOINC Long Common Name
82159-5 Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with non-probe detection

Member of these Groups

LG50060-9 Middle East respiratory syndrome coronavirus RNA|PrThr|Sys:ANYResp

Language Variants Get Info

zh-CNChinese (China)
中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:鼻咽:序数型:非探针法.基因扩增.靶向
fr-FRFrench (France)
Coronavirus MERS ARN:Présence/Seuil:Ponctuel:Nasopharynx:Qualitatif:Non-PCR amplification de cible
it-ITItalian (Italy)
Sindrome respiratoria mediorientale da Coronavirus (MERS) RNA:PrThr:Pt:Nph:Ord:Non-sonda.amp.tar
es-MXSpanish (Mexico)
Síndrome respiratorio de Oriente Medio coronavirus ARN:Presencia o umbral:Punto temporal:Nasofaringe:Ordinal:Amplificación de ácidos nucleicos con detección sin sonda
es-ESSpanish (Spain)
Coronavirus del sindrome respiratorio de Oriente medio RNA:PrThr:Punto temporal:Nasofaringe:Ord:Amplificación del objetivo no basado en sonda

LOINC FHIR® API Example - CodeSystem Request Get Info